Oropouche virus makes alarming entrance into European countries
New cases of the virus, previously spreading in South America, have now been reported in Europe. Experts warn of its dangerous effects, including meningitis, suggesting Europe may be at risk of an epidemic.
What you need to know
- The Oropouche virus, also known as "sloth fever," has been detected in Germany, Italy, and Spain. However, all cases so far originate from infections contracted outside Europe.
- Symptoms of the infection include high fever, muscle aches, and nausea. In severe cases, the virus can cause meningitis.
- The virus poses a significant threat, particularly to pregnant women. There is no vaccine available to protect against infection.
What are the symptoms of the Oropouche virus?
The Oropouche virus, or "sloth fever," manifests with high fever, muscle aches, nausea, and a skin rash. These symptoms can appear three to ten days after infection. Although they may initially seem mild, the virus can lead to serious complications, such as meningitis. The European Centre for Disease Prevention and Control (ECDC) emphasizes that fatal cases are rare, but the absence of effective treatment remains problematic.
The Oropouche virus was first identified in 1955 in a 24-year-old forestry worker on the island of Trinidad. This virus was found in three-toed sloths, suggesting these animals may play a role in transmitting the infection between insects and other animals.
Can the Oropouche virus spread in Europe?
Experts warn that the Oropouche virus is more dangerous than previously thought. Over the past year, it has spread rapidly in South America and is now appearing in Europe. The virus is transmitted through bites from certain types of midges and mosquitoes, putting people in forested areas at particular risk.
So far, nearly 20 cases have been confirmed in Europe, reported in Germany, Italy, and Spain. However, all infections have originated outside the continent.
What are the risks associated with the Oropouche virus?
The Oropouche virus can lead to serious health complications, including miscarriages and birth defects, posing a particular threat to pregnant women. About 4% of those infected develop encephalitis or meningitis, potentially leading to serious neurological problems. Experts emphasize that the lack of a vaccine and effective treatment makes the virus a significant threat to public health.
